AHP Develops Feverfew Monograph, Reference Standard
July 30, 2007
SCOTTS VALLEY, Calif.The American Herbal Pharmacopoeia (AHP) released its newest monograph, Feverfew Aerial Parts (Tanacetum parthenium) Standards of Analysis, Quality Control and Therapeutics, as well as an AHP-verified botanical reference standard. Feverfew has been traditionally used as an antipyretic and is commonly used for prevention and treatment of migraine headache, as well as asthma, rheumatoid arthritis and psoriasis. The monograph provides an up-to-date assessment of traditional and scientific data, provides methods of analysis and identification, and reviews issues surrounding the use of parthenolide as a marker compound. In addition, the feverfew reference standard material has been botanically, physically and chemically characterized to assist companies in developing internal quality control specs and aid in laboratory testing. In addition to the feverfew monograph, AHP (www.Herbal-AHP.org) offers more than 100 botanical reference materials.
You May Also Like